Innoviva (INVA) Debt Ratio (2010 - 2026)

Innoviva's (INVA) quarterly Debt Ratio came in at 0.14 in Q1 2026, down 60.73% YoY from 0.36 in Q1 2025, and down 10.84% on a QoQ basis from 0.16 in Q4 2025.

Innoviva (INVA) Debt Ratio (2010 - 2026) Analysis & Trends

Innoviva (INVA) has 17 years of Debt Ratio data on file, last reported at 0.14 in Q1 2026.

  • Quarterly Debt Ratio fell 60.73% year-over-year to 0.14 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.14 (down 60.73% YoY) and the FY2025 annual result came in at 0.16, down 54.26% from the prior year.
  • Debt Ratio eased to 0.14 in Q1 2026, from 0.16 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.44 in Q4 2022 to a low of 0.08 in Q2 2022.
  • A 5-year average of 0.3 and a median of 0.36 in 2025 frame the typical range for Debt Ratio.
  • Annual changes were most pronounced in 2022 — Debt Ratio plunged 82.91% — and 2023, when it jumped 371.44%.
  • Tracing INVA's Debt Ratio over 5 years: stood at 0.44 in 2022, then decreased by 18.22% to 0.36 in 2023, then declined by 3.97% to 0.34 in 2024, then tumbled by 54.26% to 0.16 in 2025, then fell by 10.84% to 0.14 in 2026.
  • The last three Debt Ratio figures came in at 0.14 (Q1 2026), 0.16 (Q4 2025), and 0.18 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 0.05
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.12
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.47
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 0.26
10 Innoviva 1.54 Bn 968.79 Mn 90.62 Mn 0.15

Historic Data

Download Data
DateValue
Jun 30, 2026 0.15
Mar 31, 2026 0.14
Dec 31, 2025 0.16
Sep 30, 2025 0.18
Jun 30, 2025 0.34
Mar 31, 2025 0.36
Dec 31, 2024 0.34
Sep 30, 2024 0.36
Jun 30, 2024 0.37
Mar 31, 2024 0.35
Dec 31, 2023 0.36
Sep 30, 2023 0.38
Jun 30, 2023 0.40
Mar 31, 2023 0.39
Dec 31, 2022 0.44
Sep 30, 2022 0.41
Jun 30, 2022 0.08
Mar 31, 2022 0.09
Dec 31, 2021 0.43
Sep 30, 2021 0.44